glycine + H-protein-lipoyllysine H-protein-S-aminomethyldihydrolipoyllysine + CO2
Thus, the two substrates of this enzyme are glycine and H-protein-lipoyllysine, whereas its two products are H-protein-S-aminomethyldihydrolipoyllysine and CO2.
This enzyme belongs to the family of oxidoreductases, specifically those acting on the CH-NH2 group of donors with a disulfide as acceptor. This enzyme participates in glycine, serine and threonine metabolism. It employs one cofactor, pyridoxal phosphate.
Glycine decarboxylase is a P-protein of the glycine cleavage system in eukaryotes. The glycine cleavage system catalyzes the degradation of glycine. The P protein binds the alpha-amino group of glycine through its pyridoxal phosphate cofactor. Carbon dioxide is released and the remaining methylamine moiety is then transferred to the lipoamide cofactor of the H protein.
Degradation of glycine is brought about by the glycine cleavage system, which is composed of four mitochondrial protein components: P protein (a pyridoxal phosphate-dependent glycine decarboxylase), H protein (a lipoic acid-containing protein), T protein (a tetrahydrofolate-requiring enzyme), and L protein (a lipoamide dehydrogenase).
^Kume A, Koyata H, Sakakibara T, Ishiguro Y, Kure S, Hiraga K (Mar 1991). "The glycine cleavage system. Molecular cloning of the chicken and human glycine decarboxylase cDNAs and some characteristics involved in the deduced protein structures". J Biol Chem266 (5): 3323–9. PMID1993704.
^Kure S, Narisawa K, Tada K (Mar 1991). "Structural and expression analyses of normal and mutant mRNA encoding glycine decarboxylase: three-base deletion in mRNA causes nonketotic hyperglycinemia". Biochem Biophys Res Commun174 (3): 1176–82. doi:10.1016/0006-291X(91)91545-N. PMID1996985.
Sakakibara T, Koyata H, Ishiguro Y et al. (1991). "One of the two genomic copies of the glycine decarboxylase cDNA has been deleted at a 5' region in a patient with nonketotic hyperglycinemia". Biochem. Biophys. Res. Commun.173 (3): 801–6. doi:10.1016/S0006-291X(05)80858-7. PMID2268343.CS1 maint: Explicit use of et al. (link)
Burton BK, Pettenati MJ, Block SM et al. (1989). "Nonketotic hyperglycinemia in a patient with the 9p- syndrome". Am. J. Med. Genet.32 (4): 504–5. doi:10.1002/ajmg.1320320416. PMID2773994.CS1 maint: Explicit use of et al. (link)
Hayasaka K, Kochi H, Hiraga K, Kikuchi G (1981). "Purification and properties of glycine decarboxylase, a component of the glycine cleavage system, from rat liver mitochondria and immunochemical comparison of this enzyme from various sources". J. Biochem.88 (4): 1193–9. PMID6778858.
Takayanagi M, Kure S, Sakata Y et al. (2000). "Human glycine decarboxylase gene (GLDC) and its highly conserved processed pseudogene (psiGLDC): their structure and expression, and the identification of a large deletion in a family with nonketotic hyperglycinemia". Hum. Genet.106 (3): 298–305. doi:10.1007/s004390051041. PMID10798358.CS1 maint: Explicit use of et al. (link)
Toone JR, Applegarth DA, Coulter-Mackie MB, James ER (2000). "Biochemical and molecular investigations of patients with nonketotic hyperglycinemia". Mol. Genet. Metab.70 (2): 116–21. doi:10.1006/mgme.2000.3000. PMID10873393.
Toone JR, Applegarth DA, Coulter-Mackie MB, James ER (2001). "Recurrent mutations in P- and T-proteins of the glycine cleavage complex and a novel T-protein mutation (N145I): a strategy for the molecular investigation of patients with nonketotic hyperglycinemia (NKH)". Mol. Genet. Metab.72 (4): 322–5. doi:10.1006/mgme.2001.3158. PMID11286506.
Kure S, Kojima K, Ichinohe A et al. (2002). "Heterozygous GLDC and GCSH gene mutations in transient neonatal hyperglycinemia". Ann. Neurol.52 (5): 643–6. doi:10.1002/ana.10367. PMID12402263.CS1 maint: Explicit use of et al. (link)
Boneh A, Korman SH, Sato K et al. (2005). "A single nucleotide substitution that abolishes the initiator methionine codon of the GLDC gene is prevalent among patients with glycine encephalopathy in Jerusalem". J. Hum. Genet.50 (5): 230–4. doi:10.1007/s10038-005-0243-y. PMID15864413.CS1 maint: Explicit use of et al. (link)
Korman SH, Wexler ID, Gutman A et al. (2006). "Treatment from birth of nonketotic hyperglycinemia due to a novel GLDC mutation". Ann. Neurol.59 (2): 411–5. doi:10.1002/ana.20759. PMID16404748.CS1 maint: Explicit use of et al. (link)